Group | Dogs with pathologic arrhythmias | Dogs without pathologic arrhythmias | P value |
---|---|---|---|
Number | 8/17 | 9/17 | |
Sex (female/male) | 6/2 | 3/6 | 0.09 |
Age (years) | 3.16 (IQR 1.62–4.34) | 3.26 (IQR 1.02–5.45) | 1.00 |
Weight (kg) | 25.2 (IQR 20–29.9) | 22 (IQR 17.6–36.4) | 0.92 |
Month of bite (March–May/June–September) | 4/4 | 5/4 | 0.82a |
Area of bite (nose/limb) | 4/4 | 9/0 | 0.02b |
Time from bite to admission (hours) | 1.85 (IQR 2.96–1.03) | 2 (IQR 2–3) | 0.89 |
Time from bite to 24-AECG (hours) | 2 (IQR 1.25–3.75) | 2 (IQR 2–3) | 0.76 |
Mental status at admission (normal/mildly depressed/moderately depressed/severely depressed) | 2/2/3/1 2.5 (IQR 1.25–3) | 2/4/2/1 2 (IQR 1.5–3) | 0.73 |
Degree of swelling of bite area at admission (normal/mildly/moderately/severely) | 0/3/3/2 3 (IQR 2–3.75) | 0/0/5/4 3 (IQR 3–4) | 0.13 |
Mental status day after hospitalization (normal/mildly depressed/moderately depressed/severely depressed) | 5/3/0/0 1 (IQR 1–2) | 8/1/0/0 1 (IQR 1–1) | 0.21 |
Degree of swelling of bite area day after hospitalization (normal/mildly/moderately/severely) | 1/2/4/1 3 (IQR 2–3) | 0/2/4/3 3 (IQR 2.5–4) | 0.28 |
Mental status at home (normal/mildly depressed/moderately depressed/severely depressed) | 8/0/0/0 I (IQR 1–1) | 7/2/0/0 1 (IQR 1–1.75) | 0.14 |
Mental status at revisit (normal/mildly depressed/moderately depressed/severely depressed) | 7/0/0/0b 1 (IQR 1–1) | 7/0/0/0c 1 (IQR 1–1) | 1.00 |
Dose buprenorphine (mg/kg) | 0.01 (IQR 0.006–0.012) | 0.012 (IQR 0.011–0.013) | 0.37 |
Arrhythmia or murmur detected with cardiac auscultation during hospitalization (yes/no) | 0/9 | 0/9 | |
Additional clinical findings during hospitalization | Hematoma gingiva (n = 1) Edema limb (n = 1) Edema scrotum (n = 1) Diarrhea (n = 1) | Hematoma gingiva (n = 5) | |
Additional medications during hospitalization | Maropitant (n = 1) Omeprazole (n = 1) Sucralfate (n = 2) | Maropitant (n = 1) | |
Duration of hospitalization (days) | 1.5 (IQR 1–2.75) | 1 (IQR 1–2) | 0.52 |
Time to revisit (days) | 15 (IQR 11–17) | 14 (IQR (13–16) | 0.90 |
Concentration cTnI at admission | 0.015 (IQR 0.006–0.039)c | 0.01 (IQR (0.01–0.02) | 1.00 |
Long-term complications to snake-bite (yes/no)d | 0/8 | 0/5 |